Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tatiana Kovaleva has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pax6 as a Therapeutic Target: Convergent Molecular Pathways in the Regulation of Aniridia, Neurogenesis, Neurodegeneration and Oncology

    by Marina Skorkina, Tatiana Kovaleva, Irina Predeina, Nikita Smirnov, Irina Mukhina

    The transcription factor Pax6 acts as a molecular switch regulating various phases of the cell cycle during the early stages of embryonic neurogenesis and serves as a molecular mediator integrating multiple signaling pathways involved in the development of pathophysiological conditions. In this regard, Pax6 is considered an attractive molecular target for developing new drugs aimed at combating neurodegeneration, oncology, and aniridia. The aim of this review is to examine the range of studies describing various Pax6-dependent molecular pathways to identify similarities and differences in the signaling cascades activated by Pax6 in health and disease. These insights may provide a basis for developing new therapeutic strategies targeting Pax6 as a molecular regulator. This review summarizes the data indicating the leading regulatory role of Pax6 in the neuronal cell cycle in health and pathology. It is possible that Pax6 may act as a therapeutic target in certain pathophysiological conditions; however, the effectiveness of such a strategy will depend on the substrate chain in the signaling pathway, its branching, and the redundancy of mediators involved.

  • Open Access

    Cofilin(s) and Mitochondria: Function Beyond Actin Dynamics

    by Tatiana Kovaleva, Murat Gainullin, Irina Mukhina, Vladimir Pershin, Liudmila Matskova

    ADF/cofilins form a family of small, widely expressed actin-binding proteins, regulating actin dynamics in various cellular and physiological processes in all eukaryotes from yeasts to animals. Changes in the expression of the ADF/cofilin family proteins have been demonstrated under various pathological conditions. The established role for cofilin in migration, invasion, epithelial-mesenchymal transition, apoptosis, radiotherapy and chemotherapy resistance, immune escape, and transcriptional dysregulation in malignant tumors, is explained mainly by its actin modifying activity. Moreover, drugs targeting this activity of cofilin were developed for treatment of cancers. Its multilevel regulation, extremely diverse effects in numerous forms of pathology, and the conflicting data on the functional effects of changes in cofilin expression prompted us here to point to other functions of cofilin, in addition to that of modifying actin, namely, those which affect lipid metabolism and mitochondrial homeostasis. Here, we review recent data on the expression of ADF/cofilin family proteins in various pathologies, account for the mutations and post-translational modifications of these proteins and their functional consequences, dwell on the role of K63-type ubiquitination of cofilin for its involvement in lipid metabolism and mitochondrial homeostasis, point out conflicting data in cofilin research, and describe prospects for future studies of cofilin functions.